Clinical Trial Update: Efficacy of Neoadjuvant Hyperthermic Intraperitoneal Chemotherapy in Advanced High-grade Serous Ovarian Cancer (the NHIPEC Trial) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating neoadjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced high-grade serous ovarian cancer; status not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
• neoadjuvant chemotherapy

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Hyperthermic Intraperitoneal Chemotherapy, Neoadjuvant Chemotherapy | Phase 2 | Status: UNKNOWN